FY4/23

IR PRESENTATION

June 2023

Results Overview

© 2023 AIN HOLDINGS INC. All Rights Reserved.

1

Consolidated P/L

Net sales increased 13.4% YoY and 0.2% against the plan due to new store openings and contribution of existing stores, despite the impact of the COVID-19. Ordinary profit increased 6.4% YoY and declined 5.4% against the plan due to increase of sales.

¥ million

FY4/22

FY4/23

results

revised plan

FY4/23 results

YoY

YoY

Vs plan

change

change(%)

(%)

Net sales

316,247

358,000

358,742

42,495

13.4

0.2

Gross profit

49,971

54,870

53,698

3,727

7.5

(2.1)

% of net sales

15.8

15.3

15.0

SG&A expenses

34,832

37,690

37,694

2,862

8.2

0.0

% of net sales

11.0

10.5

10.5

Operating profit

15,139

17,180

16,004

865

5.7

(6.8)

% of net sales

4.8

4.8

4.5

Ordinary profit

16,041

18,030

17,064

1,023

6.4

(5.4)

% of net sales

5.1

5.0

4.8

Profit attributable to

7,092

9,000

9,234

2,142

30.2

2.6

owners of parent

% of net sales

2.2

2.5

2.6

Earnings per

201.47

256.20

262.87

61.40

30.5

2.6

share(¥)

Figures in the table are rounded down

© 2023 AIN HOLDINGS INC. All Rights Reserved.

2

Dispensing Pharmacy Business (Consolidated)

Net sales increased 13.6% YoY and 0.0% against the plan due to new store openings including M&A and contribution of stores opened previous year. Segment profit declined 3.8% YoY and 5.4% against the plan.

¥ million

FY4/22

FY4/23

results

revised plan

FY4/23 results

YoY

YoY

Vs plan

change

change(%)

(%)

Net sales

283,111

321,560

321,577

38,466

13.6

0.0

Gross profit

38,194

41,350

39,779

1,585

4.1

(3.8)

% of net sales

13.5

12.9

12.4

SG&A expenses

13,875

16,620

16,559

2,684

19.3

(0.4)

% of net sales

4.9

5.2

5.1

Operating profit

24,319

24,730

23,220

(1,099)

(4.5)

(6.1)

% of net sales

8.6

7.7

7.2

Segment profit

25,082

25,520

24,135

(947)

(3.8)

(5.4)

% of net sales

8.9

7.9

7.5

Number of

1,099

1,210

1,209

110

10.0

(0.1)

pharmacies

Figures in the table are rounded down

© 2023 AIN HOLDINGS INC. All Rights Reserved.

3

Cosmetic and Drug Store Business (Consolidated)

Net sales increased 24.9% YoY and 3.1% against the plan due to the recovery of existing stores, contribution of stores opened in previous year, and success of cost optimization despite the impact of the COVID-19. Segment profit was 38% against the plan, ¥2,978 million above the plan.

¥ million

FY4/22

FY4/23

results

revised plan

FY4/23 results

YoY

YoY

Vs plan

Change

change(%)

(%)

Net sales

20,558

24,920

25,685

5,127

24.9

3.1

Gross profit

7,030

9,410

9,694

2,664

37.9

3.0

% of net sales

34.2

37.8

37.7

SG&A expenses

8,858

8,570

8,521

(337)

(3.8)

(0.6)

% of net sales

43.1

34.4

33.2

Operating profit

(1,827)

840

1,172

2,999

-

39.5

% of net sales

-

3.4

4.6

Segment profit

(1,764)

880

1,214

2,978

-

38.0

% of net sales

-

3.5

4.7

Number of

78

78

78

0

0.0

0.0

stores

Figures in the table are rounded down

© 2023 AIN HOLDINGS INC. All Rights Reserved.

4

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

AIN Holdings Inc. published this content on 07 June 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 June 2023 06:51:03 UTC.